StemRegenin 1 (SR1)
[ 최신 제품 인용 논문 ]
- Cornel AM, van der Sman L, van Dinter JT, Arrabito M, Dunnebach E, van Hoesel M, Kluiver TA, Lopes AP, Dautzenberg NMM, Dekker L, van Rijn JM, van den Beemt DAMH, Buhl JL, du Chatinier A, Barneh F, Lu Y, Lo Nigro L, Krippner-Heidenreich A, Sebestyén Z, Kuball J, Hulleman E, Drost J, van Heesch S, Heidenreich OT, Peng WC, Nierkens S. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1. J Immunother Cancer. 2024 Mar 21;12(3):e007538. doi: 10.1136/jitc-2023-007538. PMID: 38519054; PMCID: PMC10961533.
- Porro, G., Sarkis, R., Obergozo, C. et al. MarrowCellDLD: a microfluidic method for label-free retrieval of fragile bone marrow-derived cells. Sci Rep 13, 22462 (2023). https://doi.org/10.1038/s41598-023-47978-w.
ADDITIONAL INFORMATION
Applications:
|
FA
|
Synonyms:
|
StemRegenin-1
|
Formulation:
|
Crystalline solid
|
Chemical Name:
|
4-[2-[[2-(1-benzothiophen-3-yl)-9-propan-2-ylpurin-6-yl]amino]ethyl]phenol
|
Molecular Formula:
|
C24H23N5OS |
Molecular Weight:
|
429.5
|
CAS Number
|
1227633-49-9
|
Purity:
|
≥98%
|
Storage Conditions:
|
Product should be kept at -20°C.
|
References:
|
Thordardottir, S., Hangalapura, B. N., Hutten, T., Cossu, M., Spanholtz, J., Schaap, N., … & Dolstra, H. (2013). The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells. Stem cells and development, 23(9), 955-967. Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., … & Schultz, P. G. (2010). Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science,329(5997), 1345-1348. Gori, J. L., Chandrasekaran, D., Kowalski, J. P., Adair, J. E., Beard, B. C., D’Souza, S. L., & Kiem, H. P. (2012). Efficient generation, purification, and expansion of CD34+ hematopoietic progenitor cells from nonhuman primate–induced pluripotent stem cells. Blood, 120(13), e35-e44 |
상품평
아직 상품평이 없습니다.